Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase Blk |
---|
Ligand | BDBM4567 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_540168 (CHEMBL1026516) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Hur, W; Velentza, A; Kim, S; Flatauer, L; Jiang, X; Valente, D; Mason, DE; Suzuki, M; Larson, B; Zhang, J; Zagorska, A; Didonato, M; Nagle, A; Warmuth, M; Balk, SP; Peters, EC; Gray, NS Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase. Bioorg Med Chem Lett18:5916-9 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase Blk |
---|
Name: | Tyrosine-protein kinase Blk |
Synonyms: | B lymphoid tyrosine kinase | BLK | BLK_HUMAN | SRC | Tyrosine-protein kinase BLK (BLK) | p55-Blk |
Type: | Protein |
Mol. Mass.: | 57711.88 |
Organism: | Homo sapiens (Human) |
Description: | P51451 |
Residue: | 505 |
Sequence: | MGLVSSKKPDKEKPIKEKDKGQWSPLKVSAQDKDAPPLPPLVVFNHLTPPPPDEHLDEDK
HFVVALYDYTAMNDRDLQMLKGEKLQVLKGTGDWWLARSLVTGREGYVPSNFVARVESLE
MERWFFRSQGRKEAERQLLAPINKAGSFLIRESETNKGAFSLSVKDVTTQGELIKHYKIR
CLDEGGYYISPRITFPSLQALVQHYSKKGDGLCQRLTLPCVRPAPQNPWAQDEWEIPRQS
LRLVRKLGSGQFGEVWMGYYKNNMKVAIKTLKEGTMSPEAFLGEANVMKALQHERLVRLY
AVVTKEPIYIVTEYMARGCLLDFLKTDEGSRLSLPRLIDMSAQIAEGMAYIERMNSIHRD
LRAANILVSEALCCKIADFGLARIIDSEYTAQEGAKFPIKWTAPEAIHFGVFTIKADVWS
FGVLLMEVVTYGRVPYPGMSNPEVIRNLERGYRMPRPDTCPPELYRGVIAECWRSRPEER
PTFEFLQSVLEDFYTATERQYELQP
|
|
|
BDBM4567 |
---|
n/a |
---|
Name | BDBM4567 |
Synonyms: | 4-anilinoquinazoline deriv. 2 | BMC163482 Compound 1 | CHEMBL285063 | N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide | US9422297, PD168393 |
Type | Small organic molecule |
Emp. Form. | C17H13BrN4O |
Mol. Mass. | 369.215 |
SMILES | Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1 |
Structure |
|